Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Establishment Labs Holdings (ESTA) Equity Ratio (2017 - 2026)

Establishment Labs Holdings' quarterly Equity Ratio came in at 0.04 in Q1 2026, down 63.58% year-on-year from 0.12 in Q1 2025, and down 36.12% quarter-over-quarter from 0.07 in Q4 2025.

Establishment Labs Holdings has reported Equity Ratio for 10 years, with the latest figure at 0.04 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio fell 63.58% year-over-year to 0.04; the trailing twelve-month figure through Mar 2026 stood at 0.04 (down 63.58% YoY), and the FY2025 full-year result was 0.07, down 56.93% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.04, down from 0.07 in the prior quarter.
  • The five-year high for Equity Ratio was 0.34 in Q1 2022, with the low at 0.08 in Q1 2023.
  • Average Equity Ratio over 5 years is 0.1, with a median of 0.08 recorded in 2022.
  • Peak annual rise in Equity Ratio reached 1292.17% in 2023, while the deepest fall reached 122.61% in 2023.
  • Tracing ESTA's Equity Ratio over 5 years: stood at 0.04 in 2022, then jumped by 276.57% to 0.07 in 2023, then surged by 123.57% to 0.15 in 2024, then tumbled by 56.93% to 0.07 in 2025, then slumped by 36.12% to 0.04 in 2026.
  • The last three Equity Ratio figures came in at 0.04 (Q1 2026), 0.07 (Q4 2025), and 0.05 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 Establishment Labs Holdings 2.04 Bn 1.97 Bn 42.34 Mn 0.04

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.04
Dec 31, 2025 0.07
Sep 30, 2025 0.05
Jun 30, 2025 0.07
Mar 31, 2025 0.12
Dec 31, 2024 0.15
Sep 30, 2024 0.12
Jun 30, 2024 0.16
Mar 31, 2024 0.19
Dec 31, 2023 0.07
Sep 30, 2023 0.11
Jun 30, 2023 0.19
Mar 31, 2023 -0.08
Dec 31, 2022 -0.04
Sep 30, 2022 0.01
Jun 30, 2022 0.08
Mar 31, 2022 0.34
Dec 31, 2021 0.36
Sep 30, 2021 0.41
Jun 30, 2021 0.45
Mar 31, 2021 0.48
Dec 31, 2020 0.48
Sep 30, 2020 0.52
Mar 31, 2020 0.54
Dec 31, 2019 0.34
Sep 30, 2019 0.37
Jun 30, 2019 0.51
Mar 31, 2019 0.56
Dec 31, 2018 0.60
Sep 30, 2018 0.63
Jun 30, 2018 0.04
Dec 31, 2017 -0.09